OZAWADE

This brand name is authorized in Austria, Estonia, France, Croatia, Ireland, Italy, Lithuania, Poland

Active ingredients

The drug OZAWADE contains one active pharmaceutical ingredient (API):

1 Pitolisant UNII YV33CH63HI - PITOLISANT HYDROCHLORIDE

Pitolisant is a potent, orally active histamine H3-receptor antagonist/inverse agonist which, via its blockade of histamine auto-receptors enhances the activity of brain histaminergic neurons, a major arousal system with widespread projections to the whole brain. Pitolisant also modulates various neurotransmitter systems, increasing acetylcholine, noradrenaline and dopamine release in the brain. Read about Pitolisant

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
OZAWADE Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N07XX11		N Nervous system → N07 Other nervous system drugs → N07X Other nervous system drugs → N07XX Other nervous system drugs
Discover more medicines within N07XX11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1858642, 1858653, 1858664
Country: FR	Base de données publique des médicaments	Identifier(s): 60227166, 61247435
Country: IT	Agenzia del Farmaco	Identifier(s): 049682014, 049682026, 049682038, 049682040
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1093277, 1093278, 1093279
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100459920, 100459937